NIM

NEOS Investment Management Portfolio holdings

AUM $17.3B
1-Year Est. Return 28.96%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+28.96%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$13.4B
AUM Growth
+$5.27B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
653
New
Increased
Reduced
Closed

Top Buys

1
+$325M
2
+$284M
3
+$259M
4
AMZN icon
Amazon
AMZN
+$196M
5
AVGO icon
Broadcom
AVGO
+$156M

Top Sells

1
+$7.26M
2
+$4.66M
3
+$3.46M
4
HRI icon
Herc Holdings
HRI
+$2.37M
5
BEP icon
Brookfield Renewable
BEP
+$1.85M

Sector Composition

1 Technology 39.45%
2 Communication Services 11.82%
3 Consumer Discretionary 10.45%
4 Healthcare 7.02%
5 Financials 6.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
REPL icon
626
Replimune Group
REPL
$704M
$180K ﹤0.01%
42,966
+2,060
DAWN icon
627
Day One Biopharmaceuticals
DAWN
$1.2B
$138K ﹤0.01%
19,542
-104,768
DBRG icon
628
DigitalBridge
DBRG
$2.81B
$117K ﹤0.01%
+10,040
AXSM icon
629
Axsome Therapeutics
AXSM
$9.2B
– –
-2,327
BEP icon
630
Brookfield Renewable
BEP
$9.75B
– –
-72,683
CGEM icon
631
Cullinan Oncology
CGEM
$799M
– –
-42,692
ACAD icon
632
Acadia Pharmaceuticals
ACAD
$4.06B
– –
-10,596
ANSS
633
DELISTED
Ansys
ANSS
– –
-20,680
ARVN icon
634
Arvinas
ARVN
$762M
– –
-72,114
CNI icon
635
Canadian National Railway
CNI
$67.5B
– –
-11,357
CPRX icon
636
Catalyst Pharmaceutical
CPRX
$2.99B
– –
-11,352
CZR icon
637
Caesars Entertainment
CZR
$4.31B
– –
-17,034
DNLI icon
638
Denali Therapeutics
DNLI
$3.14B
– –
-15,174
ENPH icon
639
Enphase Energy
ENPH
$5.98B
– –
-8,922
GFL icon
640
GFL Environmental
GFL
$15.3B
– –
-30,106
GPCR icon
641
Structure Therapeutics
GPCR
$4.66B
– –
-22,880
HES
642
DELISTED
Hess
HES
– –
-24,960
JNPR
643
DELISTED
Juniper Networks
JNPR
– –
-25,399
MREO
644
Mereo BioPharma
MREO
$68.3M
– –
-102,583
PARA
645
DELISTED
Paramount Global Class B
PARA
– –
-41,909
RACE icon
646
Ferrari
RACE
$64.6B
– –
-469
RCKT icon
647
Rocket Pharmaceuticals
RCKT
$416M
– –
-32,030
TALK icon
648
Talkspace
TALK
$823M
– –
-27,834
TEVA icon
649
Teva Pharmaceuticals
TEVA
$39.5B
– –
-28,861
VKTX icon
650
Viking Therapeutics
VKTX
$3.52B
– –
-19,755
23 24 25
26
27